Join McDermott for our 13th Annual Life Sciences Dealmaking Symposium on November 6, 2024 at Boston’s stunning Omni Boston Hotel at the Seaport. You don’t want to miss a full day of valuable and candid insights from life science dealmakers on the state of dealmaking in pharma, medtech and biotech.
Why attend?
Connect with 200+ top decision-makers, including C-suite leaders, business development executives, PE and investors, founders, and strategists.
Hear from 40+ industry leaders who are back doing deals in light of improving market conditions.
Dig into transactional trends, regulatory developments and market dynamics shaping life sciences dealmaking.
Get the latest observations on global regulatory developments and the dynamic political environment that will impact cross-border transactions.
Original source can be found here.